TG Therapeutics market cap TGTX

Share price times shares outstanding: what the whole company sells for, since 2011.

TG Therapeutics is worth $8.3B at the close on Oct 23, 2026, at $54.17 a share.

That is up 57% over the last year and up 86% over five years.

Its highest close in our data was $8.8B in Sep 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$8.3B	$4.5B	$8.8B	+70%
2025	$4.9B	$4.2B	$6.8B	−4%
2024	$5.1B	$2B	$5.5B	+96%
2023	$2.6B	$1B	$5B	+50%
2022	$1.7B	$583.5M	$2.5B	−37%
2021	$2.7B	$2.2B	$7.1B	−60%
2020	$6.8B	$835.8M	$7.1B	+531%
2019	$1.1B	$333.2M	$1.1B	+228%
2018	$329.9M	$287.7M	$1.2B	−43%
2017	$579.3M	$229.9M	$924.8M	+128%
2016	$254.5M	$254.5M	$553.4M	−59%
2015	$626.6M	$564.6M	$945.8M	−12%
2014	$711.3M	$143M	$802.3M	+459%
2013	$127.3M	$92.5M	$209.6M	+45%
2012	$87.7M	$8.4M	$179M	+949%
2011	$8.4M	$8.4M	$25M	n/a

Companies in Drug Manufacturers - General nearest TG Therapeutics' size, closest first, today.

Company	Market cap
TGTXTG Therapeutics	$8.3B
PTGXProtagonist Therapeutics	$9B
CORTCorcept Therapeutics	$9.3B
ALKSAlkermes plc.	$7.3B
AMRXAmneal Pharmaceuticals	$6.5B
BMRNBiomarin Pharmaceutical	$10.8B
LGNDLigand Pharmaceuticals	$6.1B
KNSAKiniksa Pharmaceuticals International	$6B
JAZZJazz Pharmaceuticals	$13.9B
INDVIndivior Pharmaceuticals	$4.1B
ARQTArcutis Biotherapeutics	$3.9B
Peer median	$6.9B